Risks of Study Abroad Sample Clauses

Risks of Study Abroad. I understand that there are inherent dangers associated with study abroad. These risks include, but are not limited to: accidents, injury, illness, disease, death, unusual living conditions, different safety and accommodation standards, natural and weather disasters, dangerous insects and animals, criminal behavior, civil strife, terrorism, and any other harm, injury, illness or damage that can occur. I understand that Evergreen, its instructors, or its agents do not serve as guardians or insurers of my absolute safety. I have made my own assessment of these inherent dangers by reviewing the various resources listed below, and I am willing to accept these risks. initials International Organization for Medical Assistance to Travelers: Join for free. xxxxx://xxx.xxxxx.xxx/ U.S. Centers for Disease Control: xxxxx://xxx.xxx.xxx/ World Health Organization: xxxx://xxx.xxx.xxx/home U.S. State Department: Country Information: xxxxx://xxxxxx.xxxxx.xxx/content/travel/en/international- travel/International-Travel-Country-Information-Pages.html U.S. State Department: Your Health Abroad: xxxxx://xxxxxx.xxxxx.xxx/content/travel/en/international- travel/before-you-go/your-health-abroad.html
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
Risks of Study Abroad. A. I understand that participation in the Program involves risks not found in study at the College. These include risks involved in traveling to and within, and returning from, one or more foreign countries; foreign political, legal, social and economic conditions; different standards of design, safety and maintenance of buildings, public places and conveyances; local medical and weather conditions; and other matters described in the attached U.S. Department of State Country Specific Information (and Travel Warnings and/or Travel Alerts, if any) that I have received, reviewed, and initialed, and which are incorporated by reference in this Waiver and Release Agreement (“Release”).
Sample 1See All (4)
Risks of Study Abroad. I understand that there are inherent dangers associated with participating in this program, contract, or consortium away from campus. These risks include, but are not limited to: accidents, injury, illness, disease, unusual living conditions, different safety and accommodation standards, natural and weather disasters, dangerous insects and animals, criminal behavior, civil strife, terrorism, and any other harm, injury, illness or damage which may befall me. I understand that the Evergreen State College (Evergreen), its instructors, or its agents do not serve as guardians or insurers of my absolute safety. I have made my own assessment of these inherent dangers by reviewing the various study abroad materials, U.S. State Department documents, and Center for Disease Control documents listed below, and I am willing to accept these risks. _____ initials U.S. State Department Country-Specific Information Pages xxxxx://xxxxxx.xxxxx.xxx/content/passports/en/country.html I have read and understand the contents of the Country Specific Information Sheets for the countries I will be visiting. _____ initials Center for Disease Control – Traveler’s Health Pages xxxx://xxxx.xxx.xxx/travel/default.aspx I have read and understand the contents, recommendations, and requirements of the CDC Traveler’s Health Pages for my destination countries. _____ initials Evergreen Study Abroad Pre-departure Checklist and Pre-departure Orientation Materials I have read and understand the information contained in the Evergreen pre-departure materials provided to me. _____ initials
Sample 1Sample 2
Risks of Study Abroad. I am aware of and understand the risks and dangers of travel to, in, and around the Program country, including but not limited to the dangers to my own health and personal safety posed by the use of public transportation, and by civil unrest, political instability, terrorism, crime, violence, and disease. Prior to departure I will review the U.S. Consular Information and the Centers for Disease Control information applicable to travel to, in and around the Program country. By my participation in this Program, I assume, knowingly and voluntarily, each of these risks and all of the other risks that could arise out of or occur during my travel to, from, in, or around the Program country.
Sample 1
Risks of Study Abroad. I understand that participation in my program abroad involves risks not found on my home campus. These risks include without limitation traveling to and within, and returning from, WIA and other international locations; foreign political, legal, social and economic conditions; different standards of design, safety and maintenance of buildings, public places including roads and highways, and public or private transportation; local medical services or facilities; and weather conditions. The country(ies) in which my program may operate may have health and safety standards substantially different from those in the United States. I recognize that I may be subjected to potential personal or financial loss, illnesses, injuries and even death arising from participating in an activity or contact with physical surroundings; insects or animals; biological hazards such as mold, bacteria, viruses, infectious materials, bloodborne pathogens or other hazards; equipment; food, drink or shelter; or other persons. I acknowledge that this list is not inclusive of all possible risks associated with the program and certify that I have made my own investigation of these risks, understand these risks and assume them knowingly and willingly.
Sample 1
Risks of Study Abroad. I understand that participation in the Program involves risks not found in study at KCC. These risks include: traveling to and within, and returning from, one or more foreign countries; foreign political, legal, social, and economic conditions; different standards of design, safety, and maintenance of buildings, public places, and conveyances; and other matters which may be described in brochures and other written information concerning this Program, which I have received and reviewed. I have made my own investigation and am willing to accept these risks. Initials
Sample 1
Risks of Study Abroad. I understand that participation in the GCTS approved program specified above (the “Program”) involves risks not found in on-campus coursework. These include risks involved in traveling to and within, and returning from, one or more foreign countries; foreign political, legal, social, and economic conditions; local medical and weather conditions; different standards of design, safety and maintenance of buildings, public places and conveyances; and increased potential for theft of personal property (which is not covered by the Seminary’s insurance). Specifically, I understand that the risks and dangers to persons and property related to the activities involved in this trip include but are not limited to acts of terrorism, political unrest, acts of war, disease, opposition to religious groups and activities, local crime, sickness, accidents, airline travel, injuries, theft of property, immigration-related delays, kidnapping, natural disasters, transportation-related delays, civil disturbances, which may be caused by my negligence, or breaches of contract, forces of nature, human hostilities, or other causes, and knowingly accept those risks. The Seminary recognizes the extreme anxiety experienced by abducted person(s) and the next of kin. In the unlikely event of a kidnapping and demand for xxxxxx, I understand that it is not the Seminary’s policy or responsibility to pay xxxxxx. Further, I have familiarized myself with all risks and dangers associated with participation in this global education program and I am aware of all warning and travel advisories of the U.S. State Department related to the specific country to which I will be traveling. I have made my own investigation and am willing to accept these risks.
Sample 1
AutoNDA by SimpleDocs

Related to Risks of Study Abroad

  • Study Population The study was based at the San Francisco KPNC Anal Cancer Screening Clinic. We enrolled men who were identified as positive for HIV through the Kaiser HIV registry, who were aged ≥ 18 years, who were not diag- nosed with anal cancer before enrollment, and who pro- vided informed consent. In total, 363 men were enrolled between August 2009 and June 2010. The study was reviewed and approved by the institutional review boards at KPNC and at the National Cancer Institute. All partici- pants were asked to complete a self-administered ques- tionnaire to collect risk factor information. Additional information regarding HIV status and medication, sexu- ally transmitted diseases, and histopathology results were abstracted from the KPNC clinical database. For 87 of the 271 subjects without biopsy-proven AIN2 or AIN3 at the time of enrollment, follow-up infor- mation concerning outcomes from additional clinic visits up to December 2011 was available and included in the analysis to correct for the possible imperfect sensitivity of high-resolution anoscopy (HRA).13,15 Clinical Examination, Evaluation, and Results During the clinical examination, 2 specimens were col- lected by inserting a wet flocked nylon swab16 into the anal canal up to the distal rectal vault and withdrawing with rotation and lateral pressure. Both specimens were trans- ferred to PreservCyt medium (Hologic, Bedford, Mass). A third specimen was collected for routine testing for Chla- mydia trachomatis and Neisseria gonorrhea. After specimen collection, participants underwent a digital anorectal ex- amination followed by HRA. All lesions that appeared sus- picious on HRA were biopsied and sent for routine histopathological review by KPNC pathologists, and were subsequently graded as condyloma or AIN1 through AIN3. No cancers were observed in this study population. From the first specimen, a ThinPrep slide (Hologic) was prepared for routine Xxxxxxxxxxxx staining and xxxxx- xxxxx. Two pathologists (T.D. and D.T.) reviewed the slides independently. Cytology results were reported anal- ogous to the Bethesda classification17 for cervical cytology except when otherwise noted. The following categories were used: negative for intraepithelial lesion or malig- xxxxx (NILM); ASC-US; atypical squamous cells cannot rule out high-grade squamous intraepithelial lesion (HSIL) (ASC-H); low-grade squamous intraepithelial lesion (LSIL); HSIL, favor AIN2 (HSIL-AIN2); and HSIL-AIN3. ASC-H, HSIL-AIN2, and HSIL-AIN3 were combined into a single high-grade cytology category for the current analysis. Biomarker Testing Using the residual specimen from the first collection, mtm Laboratories AG (Heidelberg, Germany) performed the p16INK4a/Ki-67 dual immunostaining (‘‘p16/Ki-67 staining’’) using their CINtec Plus cytology kit according to their specifications. A ThinPrep 2000 processor (Holo- gic) was used to prepare a slide, which then was stained according to the manufacturer’s instructions. The CINtec Plus cytology kit was then applied to the unstained cytol- ogy slide for p16/Ki-67 staining. On the second collected specimen, Roche Molecular Systems (Pleasanton, Calif) tested for HR-HPV, includ- ing separate detection of HPV-16, and HPV-18 DNA, using their cobas 4800 HPV test. To prepare DNA for the cobas test, automated sample extraction was per- formed as follows: 500 lL of the PreservCyt specimen was pipetted into a secondary tube (Falcon 5-mL polypropyl- ene round-bottom tube, which measured 12-mm-by-75- mm and was nonpyrogenic and sterile). The tube was capped, mixed by vortexing, uncapped, placed on the x-480 specimen rack, and loaded onto the x-480 sample extraction module of the cobas 4800 system. The x-480 extraction module then inputs 400 lL of this material into the specimen preparation process. The extracted DNA was then tested as previously described.16 NorChip AS (Klokkarstua, Norway) also tested the second specimen for HPV-16, -18, -31, -33, and -45 HPV E6/E7 mRNA using their PreTect HPV-Proofer assay according to their specifications. All testing was per- formed masked to the results of the other assays, clinical outcomes, and patient characteristics.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Technical Feasibility of String While ICANN has encouraged and will continue to encourage universal acceptance of all top-­‐level domain strings across the Internet, certain top-­‐level domain strings may encounter difficulty in acceptance by ISPs and webhosters and/or validation by web applications. Registry Operator shall be responsible for ensuring to its satisfaction the technical feasibility of the TLD string prior to entering into this Agreement.

  • Extracurricular Activities Unless otherwise agreed to in writing by the CEO of the Sponsor, the School shall provide for its own extracurricular, athletic, and sports activities as it determines appropriate and at its own costs and it hereby fully waives the obligation, if any, of the Cleveland Municipal School District to either provide the same in any manner including permitting the School's students to participate in the programs of the Cleveland Municipal School District.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!